Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson’s Disease Using Screening of Multiple Prospective New Treatments

@inproceedings{Brundin2013LinkedCT,
  title={Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson’s Disease Using Screening of Multiple Prospective New Treatments},
  author={Patrik Brundin and Roger A. Barker and P Jeffrey Conn and Ted M Dawson and Karl K Kieburtz and A. J. Lees and Michael A. Schwarzschild and Caroline M. Tanner and T. J. Isaacs and Joy Duffen and Helen M Matthews and Richard K. H. Wyse},
  booktitle={Journal of Parkinson's disease},
  year={2013}
}
Finding new therapies for Parkinson's disease (PD) is a slow process. We assembled an international committee of experts to examine drugs potentially suitable for repurposing to modify PD progression. This committee evaluated multiple drugs currently used, or being developed, in other therapeutic areas, as well as considering several natural, non-pharmaceutical compounds. The committee prioritized which of these putative treatments were most suited to move immediately into pilot clinical trials… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 citations